Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
29.097 (87/299) |
2.27E-25 |
NIMA-related kinase 7 (NEK7)
|
|
25.357 (71/280) |
3.60E-21 |
MST-1 protein kinase (STK4)
|
|
26.042 (75/288) |
5.42E-21 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
28.938 (79/273) |
1.27E-20 |
Omphalocele kinase 1 (NUAK1)
|
|
28.014 (79/282) |
3.90E-20 |
Serine/threonine-protein kinase 3 (STK3)
|
|
25.694 (74/288) |
7.06E-20 |
NIMA-related kinase 6 (NEK6)
|
|
23.469 (69/294) |
1.12E-19 |
Serine/threonine-protein kinase 24 (STK24)
|
|
26.277 (72/274) |
1.27E-19 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.832 (79/274) |
1.61E-19 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
30.208 (87/288) |
5.75E-19 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.205 (77/273) |
6.53E-19 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
27.536 (76/276) |
8.65E-19 |
Serine/threonine-protein kinase 10 (STK10)
|
|
27.801 (67/241) |
2.34E-18 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
24.101 (67/278) |
3.83E-18 |
Serine/threonine-protein kinase 33 (STK33)
|
|
27.626 (71/257) |
4.81E-18 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
31.224 (74/237) |
8.35E-18 |
Oxidative stress responsive 1 (OXSR1)
|
|
23.248 (73/314) |
9.84E-18 |
Unc-51 like kinase 3 (ULK3)
|
|
25.484 (79/310) |
2.05E-17 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
30.342 (71/234) |
2.72E-17 |
Salt-inducible kinase 2 (SIK2)
|
|
29.242 (81/277) |
3.41E-17 |
Ste-20-related kinase (STK39)
|
|
25.159 (79/314) |
3.43E-17 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
27.046 (76/281) |
3.58E-17 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
27.113 (77/284) |
4.14E-17 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.514 (85/288) |
4.96E-17 |
Testis-specific serine kinase 2 (TSSK2)
|
|
26.596 (75/282) |
6.91E-17 |
Serine/threonine-protein kinase 25 (STK25)
|
|
25.547 (70/274) |
7.26E-17 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
27.642 (68/246) |
9.95E-17 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.618 (87/304) |
1.33E-16 |
Fused homolog (STK36)
|
|
26.754 (61/228) |
1.74E-16 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
26.619 (74/278) |
1.77E-16 |
Salt-inducible kinase 1 (SIK1)
|
|
26.619 (74/278) |
1.81E-16 |
Protein kinase C theta (PRKCQ)
|
|
25.071 (88/351) |
4.77E-16 |
Serine/threonine-protein kinase 26 (STK26)
|
|
25.887 (73/282) |
4.87E-16 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
26.446 (64/242) |
5.98E-16 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
27.215 (86/316) |
8.91E-16 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
27.530 (68/247) |
1.42E-15 |
ERK activator kinase 2 (MEK2)
|
|
28.017 (65/232) |
1.45E-15 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
25.705 (82/319) |
1.73E-15 |
Aurora kinase A (AURKA)
|
|
22.636 (79/349) |
3.38E-15 |
PAK-2 protein kinase (PAK2)
|
|
22.601 (73/323) |
4.90E-15 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
26.296 (71/270) |
5.29E-15 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
27.305 (77/282) |
5.50E-15 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
26.296 (71/270) |
1.17E-14 |
Myosin-IIIb (MYO3B)
|
|
27.586 (80/290) |
1.55E-14 |
ERK activator kinase 5 (MAP2K5)
|
|
24.340 (83/341) |
1.60E-14 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
26.280 (77/293) |
2.02E-14 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
25.979 (73/281) |
2.28E-14 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.364 (87/343) |
2.38E-14 |
ERK activator kinase 1 (MEK1)
|
|
27.074 (62/229) |
2.92E-14 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
25.714 (72/280) |
2.93E-14 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
24.232 (71/293) |
4.30E-14 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
27.119 (64/236) |
4.52E-14 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
26.715 (74/277) |
7.07E-14 |
Polo-like kinase 2 (PLK2)
|
|
22.449 (66/294) |
8.18E-14 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
22.742 (68/299) |
8.99E-14 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
27.027 (70/259) |
1.30E-13 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
22.662 (63/278) |
1.87E-13 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
24.407 (72/295) |
1.89E-13 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
24.823 (70/282) |
2.12E-13 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
24.839 (77/310) |
2.15E-13 |
SIK family kinase 3 (SIK3)
|
|
26.071 (73/280) |
2.58E-13 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
24.063 (77/320) |
2.63E-13 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
24.415 (73/299) |
2.66E-13 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
23.208 (68/293) |
2.91E-13 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
25.322 (59/233) |
3.27E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
26.577 (59/222) |
3.36E-13 |
Protein kinase C delta (PRKCD)
|
|
26.042 (75/288) |
3.63E-13 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
24.514 (63/257) |
3.80E-13 |
PAK-1 protein kinase (PAK1)
|
|
22.302 (62/278) |
3.84E-13 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
22.628 (62/274) |
4.24E-13 |
Cyclin-dependent kinase 2 (CDK2)
|
|
24.896 (60/241) |
5.64E-13 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
23.324 (87/373) |
7.65E-13 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
25.887 (73/282) |
1.05E-12 |
Myosin light chain kinase 2 (MYLK2)
|
|
27.823 (69/248) |
1.13E-12 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
25.685 (75/292) |
1.13E-12 |
Myosin light chain kinase 3 (MYLK3)
|
|
26.667 (64/240) |
1.29E-12 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
25.455 (70/275) |
1.30E-12 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.188 (67/277) |
1.37E-12 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
26.761 (76/284) |
1.38E-12 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
27.679 (62/224) |
1.47E-12 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
22.973 (68/296) |
1.59E-12 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
25.316 (60/237) |
1.64E-12 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.014 (67/279) |
1.70E-12 |
Doublecortin-like kinase 3 (DCLK3)
|
|
27.719 (79/285) |
1.91E-12 |
Cyclin-dependent kinase 3 (CDK3)
|
|
24.779 (56/226) |
1.92E-12 |
Myosin-IIIa (MYO3A)
|
|
25.606 (74/289) |
2.26E-12 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
21.222 (66/311) |
2.67E-12 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
26.639 (65/244) |
3.25E-12 |
Cyclin-dependent kinase 5 (CDK5)
|
|
24.800 (62/250) |
3.97E-12 |
BR serine/threonine kinase 1 (BRSK1)
|
|
26.667 (76/285) |
4.17E-12 |
Protein kinase N1 (PKN1)
|
|
27.206 (74/272) |
4.52E-12 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
22.145 (64/289) |
4.92E-12 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
25.877 (59/228) |
5.24E-12 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
23.718 (74/312) |
5.58E-12 |
Cyclin-dependent kinase 7 (CDK7)
|
|
24.904 (65/261) |
5.85E-12 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.180 (61/233) |
6.18E-12 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
26.316 (80/304) |
6.73E-12 |
Aurora kinase C (AURKC)
|
|
22.909 (63/275) |
6.93E-12 |
Protein kinase N2 (PKN2)
|
|
25.524 (73/286) |
7.04E-12 |
MEK kinase kinase 1 (MAP4K1)
|
|
23.322 (66/283) |
8.00E-12 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
26.496 (62/234) |
8.16E-12 |
NIMA-related kinase 2 (NEK2)
|
|
22.667 (68/300) |
1.01E-11 |
Death-associated protein kinase 1 (DAPK1)
|
|
24.476 (70/286) |
1.09E-11 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
25.000 (68/272) |
1.27E-11 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
25.979 (73/281) |
1.59E-11 |
Polo-like kinase 4 (PLK4)
|
|
23.022 (64/278) |
1.89E-11 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
26.740 (73/273) |
2.23E-11 |
Serine/threonine-protein kinase MAK (MAK)
|
|
25.225 (56/222) |
2.25E-11 |
Polo-like kinase 1 (PLK1)
|
|
22.857 (64/280) |
2.45E-11 |
Cyclin-dependent kinase 17 (CDK17)
|
|
25.379 (67/264) |
2.56E-11 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
26.646 (85/319) |
3.97E-11 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
24.380 (59/242) |
4.19E-11 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
25.448 (71/279) |
4.46E-11 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
27.039 (63/233) |
4.66E-11 |
Protein kinase C alpha (PRKCA)
|
|
23.985 (65/271) |
7.18E-11 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
23.762 (72/303) |
7.61E-11 |
PAK-4 protein kinase (PAK4)
|
|
22.667 (68/300) |
7.95E-11 |
Cyclin-dependent kinase 16 (CDK16)
|
|
25.095 (66/263) |
8.67E-11 |
Cyclin-dependent kinase 1 (CDK1)
|
|
26.840 (62/231) |
9.21E-11 |
NIMA-related kinase 1 (NEK1)
|
|
24.138 (70/290) |
1.07E-10 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.007 (71/273) |
1.09E-10 |
BR serine/threonine kinase 2 (BRSK2)
|
|
26.639 (65/244) |
1.13E-10 |
PDZ binding kinase (PBK)
|
|
22.642 (60/265) |
1.52E-10 |
Cyclin-dependent kinase 18 (CDK18)
|
|
26.522 (61/230) |
1.64E-10 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
25.833 (62/240) |
1.73E-10 |
Doublecortin-like kinase 1 (DCLK1)
|
|
23.571 (66/280) |
1.82E-10 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
23.404 (55/235) |
2.02E-10 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
23.488 (66/281) |
2.19E-10 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
23.707 (55/232) |
2.22E-10 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
26.860 (65/242) |
2.60E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
22.263 (61/274) |
3.05E-10 |
Checkpoint kinase-1 (CHK1)
|
|
27.397 (60/219) |
3.25E-10 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
25.000 (68/272) |
3.54E-10 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
20.952 (66/315) |
3.80E-10 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
27.234 (64/235) |
3.81E-10 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
26.724 (62/232) |
3.83E-10 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
26.991 (61/226) |
4.90E-10 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.322 (59/233) |
5.25E-10 |
Doublecortin-like kinase 2 (DCLK2)
|
|
24.126 (69/286) |
5.39E-10 |
Death-associated protein kinase 3 (DAPK3)
|
|
23.427 (67/286) |
5.59E-10 |
Protein kinase C epsilon (PRKCE)
|
|
25.316 (60/237) |
6.59E-10 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.000 (58/232) |
6.87E-10 |
Nik-related protein kinase (NRK)
|
|
23.899 (76/318) |
7.20E-10 |
Protein kinase G2 (PRKG2)
|
|
23.214 (65/280) |
7.82E-10 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
22.222 (72/324) |
8.31E-10 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
24.832 (37/149) |
8.33E-10 |
Protein kinase C eta type (PRKCH)
|
|
24.055 (70/291) |
9.12E-10 |
Death-associated protein kinase 2 (DAPK2)
|
|
25.210 (60/238) |
9.30E-10 |
Cyclin-dependent kinase 14 (CDK14)
|
|
24.590 (60/244) |
1.05E-09 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
22.903 (71/310) |
1.05E-09 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.039 (63/233) |
1.10E-09 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
26.457 (59/223) |
1.15E-09 |
Yet another novel kinase 2 (STK32B)
|
|
20.120 (67/333) |
1.27E-09 |
MAP kinase p38 (MAPK12)
|
|
26.316 (60/228) |
1.35E-09 |
Myosin light kinase (MYLK)
|
|
22.559 (67/297) |
1.40E-09 |
TAO kinase 3 (TAOK3)
|
|
24.549 (68/277) |
1.51E-09 |
Protein kinase C beta (PRKCB)
|
|
23.616 (64/271) |
1.52E-09 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
26.754 (61/228) |
1.82E-09 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
21.992 (53/241) |
1.97E-09 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
26.293 (61/232) |
1.99E-09 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
23.301 (72/309) |
2.15E-09 |
Misshapen-like kinase 1 (MINK1)
|
|
24.603 (62/252) |
2.39E-09 |
Stress-activated protein kinase 2b (p38 beta)
|
|
25.311 (61/241) |
2.43E-09 |
Cyclin-dependent kinase 13 (CDK13)
|
|
25.328 (58/229) |
3.01E-09 |
TAO kinase 1 (TAOK1)
|
|
26.693 (67/251) |
3.07E-09 |
Aurora kinase B (AURKB)
|
|
24.576 (58/236) |
3.37E-09 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
25.676 (57/222) |
3.93E-09 |
Cyclin-dependent kinase 15 (CDK15)
|
|
24.188 (67/277) |
3.99E-09 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
23.659 (75/317) |
4.97E-09 |
MEK kinase kinase 3 (MAP4K3)
|
|
22.456 (64/285) |
5.09E-09 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
24.625 (82/333) |
5.16E-09 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
27.679 (62/224) |
5.35E-09 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
25.328 (58/229) |
5.77E-09 |
Cyclin-dependent kinase 12 (CDK12)
|
|
26.087 (60/230) |
5.95E-09 |
Protein kinase G1 (PRKG1)
|
|
22.140 (60/271) |
7.02E-09 |
ERK activator kinase 7 (MAP2K7)
|
|
22.813 (73/320) |
8.71E-09 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
22.566 (51/226) |
1.12E-08 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
22.360 (72/322) |
1.14E-08 |
TGF-beta receptor type I (TGFBR1)
|
|
22.866 (75/328) |
1.19E-08 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
25.094 (67/267) |
1.34E-08 |
Cyclin-dependent kinase 4 (CDK4)
|
|
26.786 (60/224) |
1.49E-08 |
Rhodopsin kinase GRK1 (GRK1)
|
|
23.759 (67/282) |
1.49E-08 |
MEK kinase kinase 2 (MAP4K2)
|
|
22.109 (65/294) |
1.55E-08 |
Cyclin-dependent kinase 9 (CDK9)
|
|
23.246 (53/228) |
2.00E-08 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
26.712 (78/292) |
2.39E-08 |
Cytoplasmic DRAK1 (STK17A)
|
|
24.638 (68/276) |
2.42E-08 |
Protein kinase N3 (PKN3)
|
|
25.523 (61/239) |
2.51E-08 |
Protein kinase C iota (PRKCI)
|
|
24.034 (56/233) |
2.69E-08 |
Cyclin-dependent kinase 20 (CDK20)
|
|
24.786 (58/234) |
2.70E-08 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
22.807 (65/285) |
2.85E-08 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
25.664 (58/226) |
3.05E-08 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
22.424 (74/330) |
3.34E-08 |
Serine/threonine-protein kinase cot (COT)
|
|
22.789 (67/294) |
4.56E-08 |
Obscurin (OBSCN)
|
|
24.312 (53/218) |
5.32E-08 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
24.390 (80/328) |
5.51E-08 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
24.797 (61/246) |
6.51E-08 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
21.505 (60/279) |
7.18E-08 |
Activin receptor type IB (ACVR1B)
|
|
23.361 (57/244) |
8.24E-08 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
25.000 (60/240) |
9.43E-08 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.524 (31/105) |
1.22E-07 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
24.686 (59/239) |
1.27E-07 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
25.000 (58/232) |
1.29E-07 |
MEK kinase kinase 4 (MAP4K4)
|
|
24.506 (62/253) |
1.39E-07 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
25.974 (60/231) |
1.57E-07 |
Serine/threonine-protein kinase NLK (NLK)
|
|
34.409 (32/93) |
1.68E-07 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
25.389 (49/193) |
1.68E-07 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
22.843 (45/197) |
2.05E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
23.944 (68/284) |
2.16E-07 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
35.106 (33/94) |
2.45E-07 |
Protein kinase C gamma (PRKCG)
|
|
26.761 (38/142) |
2.52E-07 |
NF-kappa-B-activating kinase (TBK1)
|
|
26.033 (63/242) |
2.65E-07 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
27.632 (63/228) |
3.60E-07 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
26.000 (52/200) |
3.63E-07 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
25.000 (61/244) |
4.72E-07 |
Protein kinase D (PRKD1)
|
|
25.794 (65/252) |
4.75E-07 |
Serine/threonine-protein kinase 35 (STK35)
|
|
24.444 (77/315) |
5.04E-07 |
CaM-kinase IV kinase (CAMKK1)
|
|
28.758 (44/153) |
5.11E-07 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.571 (30/105) |
5.30E-07 |
Bone morphogenetic protein receptor (BMPR2)
|
|
24.633 (84/341) |
6.56E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
30.952 (39/126) |
8.13E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
23.105 (64/277) |
8.45E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
28.750 (46/160) |
8.77E-07 |
Dual specificity protein kinase TTK (MPS1)
|
|
23.077 (36/156) |
9.34E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
24.464 (57/233) |
1.15E-06 |
Peripheral plasma membrane protein CASK (CASK)
|
|
24.303 (61/251) |
1.21E-06 |
Wee1-like protein kinase (WEE1)
|
|
23.333 (70/300) |
1.26E-06 |
Rhodopsin kinase GRK7 (GRK7)
|
|
23.451 (53/226) |
1.34E-06 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
22.311 (56/251) |
1.58E-06 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
28.966 (42/145) |
1.91E-06 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
28.000 (63/225) |
2.17E-06 |
Protein kinase C zeta (PRKCZ)
|
|
21.769 (64/294) |
2.97E-06 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
23.789 (54/227) |
3.20E-06 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
30.702 (35/114) |
3.25E-06 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
24.286 (51/210) |
3.32E-06 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
22.907 (52/227) |
3.38E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
36.538 (38/104) |
4.82E-06 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
30.303 (30/99) |
4.85E-06 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.273 (42/154) |
5.38E-06 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
25.248 (51/202) |
5.39E-06 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
22.845 (53/232) |
7.70E-06 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
25.424 (60/236) |
8.37E-06 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
27.072 (49/181) |
1.19E-05 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
22.523 (50/222) |
1.40E-05 |
Wee1-like protein kinase 2 (WEE2)
|
|
26.111 (47/180) |
1.66E-05 |
Titin (TTN)
|
23.043 (53/230) |
2.01E-05 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
22.857 (56/245) |
2.21E-05 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
21.714 (76/350) |
2.77E-05 |
Cyclin-dependent kinase 19 (CDK19)
|
|
28.085 (66/235) |
2.89E-05 |
Activin receptor type IIA (ACVR2A)
|
|
23.214 (52/224) |
2.90E-05 |
Cyclin-dependent kinase 8 (CDK8)
|
|
26.047 (56/215) |
3.06E-05 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
24.896 (60/241) |
3.60E-05 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
24.194 (45/186) |
3.62E-05 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
23.692 (77/325) |
4.71E-05 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
21.702 (51/235) |
4.71E-05 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
31.183 (29/93) |
4.79E-05 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
22.472 (40/178) |
5.14E-05 |
Rho-associated protein kinase 2 (ROCK2)
|
|
23.810 (55/231) |
5.17E-05 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
29.000 (29/100) |
5.88E-05 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.862 (45/181) |
6.05E-05 |
Casein kinase II alpha (CSNK2A1)
|
|
26.923 (28/104) |
6.15E-05 |
Cyclin-G-associated kinase (GAK)
|
|
20.721 (69/333) |
6.28E-05 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
31.183 (29/93) |
7.10E-05 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
22.041 (54/245) |
8.65E-05 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
31.183 (29/93) |
8.84E-05 |
CDC-like kinase 2 (CLK2)
|
|
22.917 (55/240) |
1.05E-04 |
Rho-associated protein kinase 1 (ROCK1)
|
|
24.242 (56/231) |
1.08E-04 |
CDC-like kinase 1 (CLK1)
|
|
24.800 (62/250) |
1.14E-04 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
22.222 (48/216) |
1.18E-04 |
Citron Rho-interacting kinase (CIT)
|
|
24.275 (67/276) |
1.42E-04 |
Triple functional domain protein (TRIO)
|
|
23.684 (54/228) |
1.49E-04 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
24.684 (39/158) |
1.66E-04 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
25.962 (27/104) |
2.20E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.087 (60/230) |
2.23E-04 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
28.155 (29/103) |
2.31E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
33.645 (36/107) |
2.36E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.000 (58/232) |
2.36E-04 |
Serine/threonine-protein kinase 40 (STK40)
|
|
22.353 (38/170) |
3.25E-04 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
25.974 (40/154) |
3.39E-04 |
Cyclin-dependent kinase 10 (CDK10)
|
|
24.201 (53/219) |
3.50E-04 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
23.305 (55/236) |
1.00E-03 |
Adaptor-associated kinase 1 (AAK1)
|
|
23.350 (46/197) |
1.00E-03 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
24.670 (56/227) |
1.00E-03 |
Tribbles homolog 2 (TRIB2)
|
|
24.324 (36/148) |
1.00E-03 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
26.230 (64/244) |
1.00E-03 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
22.321 (75/336) |
2.00E-03 |
CDC-like kinase 4 (CLK4)
|
|
24.481 (59/241) |
2.00E-03 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
24.503 (37/151) |
2.00E-03 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
26.117 (76/291) |
2.00E-03 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
29.808 (31/104) |
3.00E-03 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
22.881 (54/236) |
3.00E-03 |
Activin receptor type IIB (ACVR2B)
|
|
21.545 (53/246) |
4.00E-03 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
24.167 (29/120) |
5.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |